By
Olivia Rinaldi
White House reporter
Olivia Rinaldi is a White House reporter at CBS News. She covered President Trump's 2024 presidential campaign and was previously an associate producer for "CBS Evening News with Norah O'Donnell" and a broadcast associate for "Face the Nation." She is based in Washington, D.C.
/ CBS News
A first-of-its-kind weight loss pill will become the latest drug to be offered on President Trump's cost comparison platform "Trump Rx," CBS News exclusively learned.
Foundayo, a GLP-1 drug, is a first-of-its-kind weight loss pill that doesn't need to be taken on an empty stomach, expanding access for those who are needle averse.
A White House official says TrumpRx, the low-cost pharmaceutical comparison website launched by the administration in February, will provide coupons for Foundayo to Americans without insurance starting at $149 for the first dose.
The refills will be marked at $199 and future prescriptions will be $299.
The pill will also be sold at a similar price on Eli Lilly's direct to consumer platform "Lilly Direct."
Though the prices are the same, a White House official tells CBS news they believe TrumpRx has a greater reach than the drugmaker's platform and serves as a "one stop shop" for consumers to evaluate all GLP-1s on the market.
The cost for Americans on Medicare will be around $50 and Americans on private insurance for about $25.
A White House official told CBS News that the pill could be featured on TrumpRx as soon as Thursday.
Foundayo is also the first new drug approved under the FDA's priority voucher program. The program, which was announced last June, was intended to shorten the time it takes to review drugs from 10 to 12 months down to just two months.
The FDA approved the Eli Lilly drug just 50 days after filing. The company plans to start shipping the pill on April 6.
FDA approves new weight loss pill
What to know about the new weight loss pill approved by the FDA
(02:20)
